Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment
Journal article published in 2021 by
E. Boerrigter 
,
G. E. Benoist,
I. M. van Oort,
G. W. Verhaegh,
O. van Hooij ,
L. Groen,
F. Smit,
I. M. Oving,
P. de Mol,
T. J. Smilde,
D. M. Somford ,
N. Mehra,
J. A. Schalken,
N. P. van Erp
,
G. E. Benoist,
I. M. van Oort,
G. W. Verhaegh,
O. van Hooij ,
L. Groen,
F. Smit,
I. M. Oving,
P. de Mol,
T. J. Smilde,
D. M. Somford ,
N. Mehra,
J. A. Schalken,
N. P. van Erp
This paper is made freely available by the publisher.
Full text: Download
Data provided by 